Therapeutic Advances in Infectious Disease (TAID)
Journal Descriptions
Therapeutic Advances in Infectious Disease is an international, peer-reviewed, fully open-access medical journal published by SAGE Publishing. Launched in 2013, the journal provides a platform for the rapid dissemination of high-quality research, reviews, case reports, and scholarly commentaries covering all aspects of infectious diseases and infection prevention. It is intended for infectious disease specialists, clinicians, microbiologists, epidemiologists, pharmacists, public health professionals, and biomedical researchers. The journal publishes research on bacterial, viral, fungal, and parasitic infections, antimicrobial resistance, antimicrobial stewardship, vaccine development, infection control, tropical diseases, emerging and re-emerging pathogens, HIV/AIDS, COVID-19, hepatitis, tuberculosis, fungal infections, and global health. It also welcomes studies addressing the social determinants of infectious diseases, diagnostic innovations, therapeutic strategies, and public health interventions. All manuscripts undergo rigorous peer review to ensure scientific quality and clinical relevance. The journal is indexed in major bibliographic databases including PubMed, PubMed Central, Scopus, and Web of Science (ESCI), providing broad international visibility. As a Gold Open Access journal, all accepted articles are freely available online immediately after publication, supporting the rapid exchange of scientific knowledge and evidence-based clinical practice in infectious diseases.
Therapeutic Advances in Infectious Disease (TAID) is :-
-
International, Peer-Reviewed, Open Access, Refereed, Infectious Diseases, Clinical Infectious Diseases, Medical Microbiology, Virology, Antimicrobial Resistance, Infection Prevention and Control, Epidemiology, Tropical Medicine, Public Health, Vaccine Research, viral, fungal, and parasitic infections, antimicrobial resistance, antimicrobial stewardship, vaccine development, infection control, tropical diseases, emerging and re-emerging pathogens, HIV/AIDS, COVID-19, hepatitis, tuberculosis, fungal infections, global health , Online or Print , Continuously Journal
- UGC Approved, ISSN Approved: P-ISSN P-ISSN: 2049-9361, E-ISSN: 2049-937X, Established: 2013,
- Does Not Provide Crossref DOI
-
Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE